BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Xiang JY, Ouyang Q, Li GD, Xiao NP. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol 2008; 14(1): 53-57 [PMID: 18176961 DOI: 10.3748/wjg.14.53]
URL: https://www.wjgnet.com/1007-9327/full/v14/i1/53.htm
(0) (0) (7068) (80)
Number Citing Articles
1
Fang Chen, Yue Hu, Yi-Hong Fan, Bin Lv. Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.679264
2
Mercedes Márquez, Clotilde Fernández Gutiérrez del Álamo, José Antonio Girón-González. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity. World Journal of Gastroenterology 2016; 22(4): 1433-1448 doi: 10.3748/wjg.v22.i4.1433
3
Lirui Wang, Cristina Llorente, Phillipp Hartmann, An-Ming Yang, Peng Chen, Bernd Schnabl. Methods to determine intestinal permeability and bacterial translocation during liver disease. Journal of Immunological Methods 2015; 421 doi: 10.1016/j.jim.2014.12.015
4
Susan Levenstein, Cosimo Prantera. Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease. American Journal of Gastroenterology 2016; 111(10) doi: 10.1038/ajg.2016.278
5
Joseph Katzinger. Textbook of Natural Medicine. 2020;  doi: 10.1016/B978-0-323-43044-9.00028-5
6
Martine De Vos, Edouard J. Louis, Jørgen Jahnsen, Jo G.P. Vandervoort, Maja Noman, Olivier Dewit, Geert R. DʼHaens, Denis Franchimont, Filip J. Baert, Roald A. Torp, Magne Henriksen, Philippe M.R. Potvin, Philippe P. Van Hootegem, Pieter M. Hindryckx, Tom G. Moreels, Arnaud Collard, Lars Normann Karlsen, Eirik Kittang, Guy Lambrecht, Tore Grimstad, Jonas Koch, Idar Lygren, Jean-Claude R.J. Coche, Fazia Mana, André Van Gossum, Jacques Belaiche, Mike R. Cool, Fernand Fontaine, Jean-Marc G. Maisin, Vinciane Muls, Bart Neuville, Dirk A. J. Staessen, Gert A. Van Assche, Thomas de Lange, Inger Camilla Solberg, Bert J.K. Vander Cruyssen, Severine A.R.A. Vermeire. Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy. Inflammatory Bowel Diseases 2013; 19(10) doi: 10.1097/MIB.0b013e31829b2a37
7
Ying Cui, Jun Zhang, Yan Chen, Le-gao Chen. Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk. Digestive Diseases and Sciences 2021; 66(5) doi: 10.1007/s10620-020-06350-y
8
H Cypers, G Varkas, S Beeckman, K Debusschere, T Vogl, J Roth, M B Drennan, M Lavric, D Foell, C A Cuvelier, M De Vos, J Delanghe, F Van den Bosch, D Elewaut. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Annals of the Rheumatic Diseases 2016; 75(7) doi: 10.1136/annrheumdis-2015-208025
9
Dora Grgić, Karlo Golubić, Marko Brinar, Željko Krznarić. Predictive value of faecal calprotectin in ulcerative colitis – single centre experience. Annals of Medicine 2022; 54(1) doi: 10.1080/07853890.2022.2082518
10
Joseph Amara, Youakim Saliba, Joelle Hajal, Viviane Smayra, Jules-Joel Bakhos, Raymond Sayegh, Nassim Fares. Circadian Rhythm Disruption Aggravates DSS-Induced Colitis in Mice with Fecal Calprotectin as a Marker of Colitis Severity. Digestive Diseases and Sciences 2019; 64(11) doi: 10.1007/s10620-019-05675-7
11
Katarzyna Lewandowska, Olga Ciepiela. The correlation between the concentration of faecal calprotectin and markers of inflammation in children with gastrointestinal disorders. Diagnostyka Laboratoryjna 2017; 53(2) doi: 10.5604/01.3001.0013.7968
12
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterología y Hepatología (English Edition) 2020; 43(1) doi: 10.1016/j.gastre.2019.08.005
13
Allison L. Goetsch, Dana Kimelman, Teresa K. Woodruff. Fertility Preservation and Restoration for Patients with Complex Medical Conditions. 2017;  doi: 10.1007/978-3-319-52316-3_15
14
Kousaku Kawashima, Shunji Ishihara, Takafumi Yuki, Koji Onishi, Yoshinori Kushiyama, Hirofumi Fujishiro, Youichi Miyaoka, Mika Yuki, Yoshinori Komazawa, Takashi Tanimura, Hiroki Sonoyama, Yasumasa Tada, Ryusaku Kusunoki, Akihiko Oka, Nobuhiko Fukuba, Naoki Oshima, Ichiro Moriyama, Yoshikazu Kinoshita. Therapeutic Efficacy of pH-Dependent Release Formulation of Mesalazine on Active Ulcerative Colitis Resistant to Time-Dependent Release Formulation: Analysis of Fecal Calprotectin Concentration. BioMed Research International 2014; 2014 doi: 10.1155/2014/342751
15
Cong Dai, Zi-Yuan Dong, Yi-Nuo Wang, Yu-Hong Huang, Min Jiang. Development and validation of a nomogram to predict Non-Response to 5-aminosalicylic acid in patients with ulcerative colitis. Revista Española de Enfermedades Digestivas 2023;  doi: 10.17235/reed.2023.9703/2023
16
Hrishikesh Samant, Devendra Desai, Philip Abraham, Anand Joshi, Tarun Gupta, Alpa Dherai, Tester Ashavaid. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease. Indian Journal of Gastroenterology 2015; 34(6) doi: 10.1007/s12664-015-0608-x
17
Hossam M. Elsaadany, Mohammed F. Almaghraby, Awatif A. Edrees, Yasser M. Elsherbiny, Roobina K. Kumar. Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis. The Egyptian Journal of Internal Medicine 2016; 28(1) doi: 10.4103/1110-7782.182956
18
Nages Nagaratnam, Kujan Nagaratnam, Gary Cheuk. Geriatric Diseases. 2018;  doi: 10.1007/978-3-319-33434-9_16
19
Dae Bum Kim, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Hea Jung Sung, Chang Nyol Paik, Woo Chul Chung, Ji-Han Jung, Hyun Joo Choi. Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative Colitis. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/5832051
20
Ryosuke Horio, Jun Kato, Yuki Ohta, Takashi Taida, Keiko Saito, Miyuki Iwasaki, Yusuke Ozeki, Yushi Koshibu, Nobuaki Shu, Makoto Furuya, Yuhei Oyama, Hayato Nakazawa, Yukiyo Mamiya, Chihiro Goto, Satsuki Takahashi, Akane Kurosugi, Michiko Sonoda, Tatsuya Kaneko, Naoki Akizue, Kenichiro Okimoto, Tomoaki Matsumura, Naoya Kato. Risk factors for clinical relapse in patients with ulcerative colitis who are in clinical remission but with endoscopic activity. JGH Open 2024; 8(7) doi: 10.1002/jgh3.70011
21
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterología y Hepatología 2020; 43(1) doi: 10.1016/j.gastrohep.2019.08.011
22
Eun Hye Lee, Jae Sung Ko, Jeong Kee Seo. Correlations of Plasma Citrulline Levels With Clinical and Endoscopic Score and Blood Markers According to Small Bowel Involvement in Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition 2013; 57(5) doi: 10.1097/MPG.0b013e31829e264e
23
Francisco Rodríguez-Moranta, Triana Lobatón, Lorena Rodríguez-Alonso, Jordi Guardiola. Calprotectina fecal en el diagnóstico de enfermedades inflamatorias. Gastroenterología y Hepatología 2013; 36(6) doi: 10.1016/j.gastrohep.2012.10.008
24
Serkan Torun, Bilge Demirel Tunc, Burak Suvak, Hakan Yildiz, Adnan Tas, Abdurrahim Sayilir, Yasemin Ozin Ozderin, Yavuz Beyazit, Ertugrul Kayacetin. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severity. Clinics and Research in Hepatology and Gastroenterology 2012; 36(5) doi: 10.1016/j.clinre.2012.06.004
25
Bruno Lima Rodrigues, Márcia Carolina Mazzaro, Cristiane Kibune Nagasako, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal. Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores. World Journal of Gastrointestinal Endoscopy 2020; 12(12): 504-520 doi: 10.4253/wjge.v12.i12.504
26
Anne-Claire Frin, Jérôme Filippi, Gilles Boschetti, Bernard Flourie, Jocelyne Drai, Patricia Ferrari, Xavier Hebuterne, Stéphane Nancey. Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis. Digestive and Liver Disease 2017; 49(1) doi: 10.1016/j.dld.2016.09.001
27
Jost Langhorst, James Boone, Romy Lauche, Andreas Rueffer, Gustav Dobos. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial. Journal of Crohn's and Colitis 2016; 10(7) doi: 10.1093/ecco-jcc/jjw044
28
Yang Woon Lee, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Dae Bum Kim, Yeon Ji Kim, Woo Chul Chung, Chang-Nyol Paik. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity. The Korean Journal of Internal Medicine 2019; 34(1) doi: 10.3904/kjim.2016.324
29
Nages Nagaratnam, Kujan Nagaratnam, Gary Cheuk. Geriatric Diseases. 2017;  doi: 10.1007/978-3-319-32700-6_16-1
30
Qian Guo, Xicao Zha, Chun Li, Yuan Jia, Lei Zhu, Jianping Guo, Yin Su. Serum calprotectin—a promising diagnostic marker for adult-onset Still’s disease. Clinical Rheumatology 2016; 35(1) doi: 10.1007/s10067-015-3108-6
31
Giulia Roda, Alessandra Caponi, Marco Benevento, Paolo Nanni, Laura Mezzanotte, Andrea Belluzzi, Lloyd Mayer, Aldo Roda. New proteomic approaches for biomarker discovery in inflammatory bowel disease. Inflammatory Bowel Diseases 2010; 16(7) doi: 10.1002/ibd.21212
32
Saranya Sasidharan, Alexa N Sasson, Kevin M Shannon, Ashwin N Ananthakrishnan. Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe Colitis. Inflammatory Bowel Diseases 2022; 28(12) doi: 10.1093/ibd/izac011
33
Andrea Girman. Textbook of Natural Medicine. 2013;  doi: 10.1016/B978-1-4377-2333-5.00027-4
34
Harland S. Winter, Piotr Krzeski, Melvin B. Heyman, Eduardo Ibarguen‐Secchia, Barbara Iwanczak, Maciej Kaczmarski, Jaroslaw Kierkus, Sanja Kolaček, Bankole Osuntokun, J. Antonio Quiros, Manoj Shah, Bruce Yacyshyn, Preston M. Dunnmon. High‐ and Low‐Dose Oral Delayed‐Release Mesalamine in Children With Mild‐to‐Moderately Active Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition 2014; 59(6) doi: 10.1097/MPG.0000000000000530
35
Athanasios Kostas, Spyros I Siakavellas, Charalambos Kosmidis, Anna Takou, Joanna Nikou, Georgios Maropoulos, John Vlachogiannakos, George V Papatheodoridis, Ioannis Papaconstantinou, Giorgos Bamias. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World Journal of Gastroenterology 2017; 23(41): 7387-7396 doi: 10.3748/wjg.v23.i41.7387
36
Sofija I. Lugonja, Ivana L. Pantic, Tamara M. Milovanovic, Vesna M. Grbovic, Bojana M. Djokovic, Željko D. Todorovic, Stefan M. Simovic, Raša H. Medovic, Nebojsa D. Zdravkovic, Natasa D. Zdravkovic. Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation. Medicina 2023; 59(3) doi: 10.3390/medicina59030554
37
Aranzazu Jauregui-Amezaga, María López-Cerón, Montserrat Aceituno, Mireya Jimeno, Cristina Rodríguez de Miguel, Susana Pinó-Donnay, Michel Zabalza, Miquel Sans, Elena Ricart, Ingrid Ordás, Begoña González-Suárez, Miriam Cuatrecasas, Josep Llach, Julian Panés, María Pellise. Accuracy of Advanced Endoscopy and Fecal Calprotectin for Prediction of Relapse in Ulcerative Colitis. Inflammatory Bowel Diseases 2014; 20(7) doi: 10.1097/MIB.0000000000000069
38
Sayaka Yamaguchi, Yoshiaki Takeuchi, Katsuhito Arai, Katsuyuki Fukuda, Yuichiro Kuroki, Kunio Asonuma, Hiroshi Takahashi, Masayuki Saruta, Hitoshi Yoshida. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis. Journal of Gastroenterology and Hepatology 2016; 31(1) doi: 10.1111/jgh.13061
39
Danusia Onişor, Alina Boeriu, Ofelia Pascarenco, Olga Brusnic, Daniela Dobru. Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study. Revista Romana de Medicina de Laborator 2018; 26(3) doi: 10.2478/rrlm-2018-0006
40
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, Waliul Islam Khan. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. Journal of Gastroenterology 2016; 51(5) doi: 10.1007/s00535-016-1182-4
41
Tawfik El-Raouf. Long Pentraxin PTX 3 and Faecal Calprotectin as a Non Invasive Biomarkers for Ulcerative Colitis. Archives of Clinical Gastroenterology 2017;  doi: 10.17352/2455-2283.000030
42
Hassan Vosoughinia, Maryam Latifnia, Mojtaba Fattahi Abdizadeh, Elham Mokhtari Amirmajdi, Mitra Ahadi. The Relation Between Fecal Calprotectin and the Rate of Clinical Activity of Ulcerative Colitis. Razavi International Journal of Medicine 2018; 6(1) doi: 10.5812/rijm.14533
43
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology 2018; 24(33): 3681-3694 doi: 10.3748/wjg.v24.i33.3681
44
Arafat Kassem, Hosam A.S. Shabana, Mabrouk M. Aboelenin. Comparative study the levels of plasma transforming growth factor-β1, serum crp, fecal lactoferrin, and fecal calprotectin as biomarkers for disease activity in Egyptian patients with ulcerative colitis. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2019; 3(1) doi: 10.4103/sjamf.sjamf_58_18
45
Dan Turner, Cynthia H. Seow, Gordon R. Greenberg, Anne M. Griffiths, Mark S. Silverberg, A. Hillary Steinhart. A Systematic Prospective Comparison of Noninvasive Disease Activity Indices in Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2009; 7(10) doi: 10.1016/j.cgh.2009.06.024
46
Tarang Taghvaei, Iradj Maleki, Farshad Nagshvar, Hafez Fakheri, Vahid Hosseini, Seyed Mohammad Valizadeh, Hassan Neishaboori. Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis. Internal and Emergency Medicine 2015; 10(3) doi: 10.1007/s11739-014-1144-x
47
Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa. Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment. European Journal of Gastroenterology & Hepatology 2020; 32(9) doi: 10.1097/MEG.0000000000001731
48
Ali Ghweil, Ashraf Khodeary, Shereen Philip Aziz. Diagnostic Value of Fecal Calprotectin and Serum MMP-9 in Diagnosing Disease Activity of Ulcerative Colitis. Open Journal of Gastroenterology 2018; 8(06) doi: 10.4236/ojgas.2018.86026
49
Bincy P. Abraham, Selvi Thirumurthi. Clinical significance of inflammatory markers. Current Gastroenterology Reports 2009; 11(5) doi: 10.1007/s11894-009-0055-x
50
Rachele Ciccocioppo, Venerina Imbesi, Elena Betti, Vincenzo Boccaccio, Peter Kruzliak, Alessandra Gallia, Giuseppina Cristina Cangemi, Gabriella Carnevale Maffe, Alessandro Vanoli, Serena Merante, Mara De Amici, Colomba Falcone, Catherine Klersy, Gino Roberto Corazza. The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn’s Disease: A Cross-Sectional Study. Digestive Diseases and Sciences 2015; 60(8) doi: 10.1007/s10620-015-3619-7
51
Dan Turner, Frank M. Ruemmele, Esther Orlanski‐Meyer, Anne M. Griffiths, Javier Martin de Carpi, Jiri Bronsky, Gabor Veres, Marina Aloi, Caterina Strisciuglio, Christian P. Braegger, Amit Assa, Claudio Romano, Séamus Hussey, Michael Stanton, Mikko Pakarinen, Lissy de Ridder, Konstantinos Katsanos, Nick Croft, Victor Navas‐López, David C. Wilson, Sally Lawrence, Richard K. Russell. Management of Paediatric Ulcerative Colitis, Part 1. Journal of Pediatric Gastroenterology and Nutrition 2018; 67(2) doi: 10.1097/MPG.0000000000002035
52
Miguel Regueiro, Joseph Rodemann, Kevin E. Kip, Melissa Saul, Jason Swoger, Leonard Baidoo, Marc Schwartz, Arthur Barrie, David Binion. Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity. Inflammatory Bowel Diseases 2011; 17(4) doi: 10.1002/ibd.21445
53
Henrike M. Hamer, Daisy M.A.E. Jonkers, Steven A.L.W. Vanhoutvin, Freddy J. Troost, Ger Rijkers, Adriaan de Bruïne, Aalt Bast, Koen Venema, Robert-Jan M. Brummer. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clinical Nutrition 2010; 29(6) doi: 10.1016/j.clnu.2010.04.002
54
Liang Zhang, Craig D. Wallace, Jamie E. Erickson, Christine M. Nelson, Stephanie M. Gaudette, Calvin S. Pohl, Samuel D. Karsen, Gricelda H. Simler, Ruoqi Peng, Christopher A. Stedman, F. Stephen Laroux, Marc A. Wurbel, Rajesh V. Kamath, Bradford L. McRae, Annette J. Schwartz Sterman, Soumya Mitra. Near infrared readouts offer sensitive and rapid assessments of intestinal permeability and disease severity in inflammatory bowel disease models. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-61756-y
55
Gabriela Maria Henz Giovelli, Ornella Sari Cassol, Marcio Lubini, Angelina Dantas Costa, Édina Gaviraghi, Laura de Cezaro Martini. Evaluation of Proactive Therapeutic Drug Monitoring Application in Infliximab Users in Ulcerative Colitis. Journal of Coloproctology 2023; 43(04) doi: 10.1055/s-0043-1776889
56
Anna Luisa Bathe, Eirini Mavropoulou, Nicolae-Catalin Mechie, Golo Petzold, Volker Ellenrieder, Steffen Kunsch, Ahmad Amanzada, Bruno Bonaz. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis. PLOS ONE 2019; 14(10) doi: 10.1371/journal.pone.0223893
57
Michelle Vu, Daniel W. Hommes. Medical Therapy of Ulcerative Colitis. 2014;  doi: 10.1007/978-1-4939-1677-1_42
58
Cansel Turkay, Benan Kasapoglu. Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics 2010; 65(2) doi: 10.1590/S1807-59322010000200015
59
Marco Daperno, Fabiana Castiglione, Lissy de Ridder, Iris Dotan, Martti Färkkilä, Jon Florholmen, Gerald Fraser, Walter Fries, Xavier Hebuterne, Peter Laszlo Lakatos, Julián Panés, Jordi Rimola, Edouard Louis. Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2011; 5(5) doi: 10.1016/j.crohns.2011.07.003
60
Gerda C Leitner, Harald Vogelsang. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 5-20 doi: 10.4292/wjgpt.v7.i1.5
61
Anastassios C. Manolakis, Andreas N. Kapsoritakis, Elisavet K. Tiaka, Spyros P. Potamianos. Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2011; 56(6) doi: 10.1007/s10620-010-1494-9
62
Wei-Chen Lin, Jau-Min Wong, Chien-Chih Tung, Ching-Pin Lin, Jen-Wei Chou, Horng-Yuan Wang, Ming-Jium Shieh, Chin-Hao Chang, Heng-Hsiu Liu, Shu-Chen Wei, Taiwan Society of Inflammatory Bowel Disease Multicenter Study. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients. World Journal of Gastroenterology 2015; 21(48): 13566-13573 doi: 10.3748/wjg.v21.i48.13566
63
Yoshiki Matsuda, Nobuyuki Ozawa, Takiko Shinozaki, Ken-ichi Wakabayashi, Kosuke Suzuki, Yusuke Kawano, Iwao Ohtsu, Yoshitaka Tatebayashi. Ergothioneine, a metabolite of the gut bacterium Lactobacillus reuteri, protects against stress-induced sleep disturbances. Translational Psychiatry 2020; 10(1) doi: 10.1038/s41398-020-0855-1
64
SANG-YOUN JUNG, YONG-BEOM PARK, YOU-JUNG HA, KWANG-HOON LEE, SOO-KON LEE. Serum Calprotectin as a Marker for Disease Activity and Severity in Adult-onset Still’s Disease. The Journal of Rheumatology 2010; 37(5) doi: 10.3899/jrheum.091120
65
Sun-Ho Lee, Min-Ju Kim, Kiju Chang, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0669-7
66
Usta Büşra, Gür Vural Demet, Birinci Asuman, Ustaoğlu Dede Müge. Correlation between fecal biomarkers and the presence of antineutrophil cytoplasmic antibodies with ulcerative colitis disease activity. Revista Romana de Medicina de Laborator 2025; 33(1) doi: 10.2478/rrlm-2025-0001
67
Bincy P. Abraham, Sunanda Kane. Fecal Markers: Calprotectin and Lactoferrin. Gastroenterology Clinics of North America 2012; 41(2) doi: 10.1016/j.gtc.2012.01.007
68
Shunsuke Sekiya, Makoto Murata, Satoshi Arai, Hiroshi Murayama, Atushi Kawasaki, Noriyuki Ashida, Kohki Okada, Masaki Ikemoto. Enzyme-linked immunosorbent assay for S100A9 in the stool of rats with dextran sulfate sodium-induced colitis. Journal of Immunological Methods 2016; 439 doi: 10.1016/j.jim.2016.09.009
69
Rayna Shentova-Eneva, Tsvetelina Velikova. Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?. Gastroenterology Insights 2020; 11(2) doi: 10.3390/gastroent11020009
70
O. A. El-Kawy, M. H. Sanad, F. Marzook. 99mTc-Mesalamine as potential agent for diagnosis and monitoring of ulcerative colitis: labelling, characterisation and biological evaluation. Journal of Radioanalytical and Nuclear Chemistry 2016; 308(1) doi: 10.1007/s10967-015-4338-4
71
Almina Jukic, Latifa Bakiri, Erwin F. Wagner, Herbert Tilg, Timon E. Adolph. Calprotectin: from biomarker to biological function. Gut 2021; 70(10) doi: 10.1136/gutjnl-2021-324855
72
Ashish Kumar Jha, Madhur Chaudhary, Vishwa Mohan Dayal, Amarendra Kumar, Sanjeev Kumar Jha, Praveen Jha, Shubham Purkayastha, Ravish Ranjan. Optimal cut‐off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?. JGH Open 2018; 2(5) doi: 10.1002/jgh3.12074
73
Shimaa El Sharawy, Hemat El-Horany, Ibrahim Amer. Corrected ESR/Albumin Ratio as a Simple, Practical Marker Predicts the Severity in Egyptian Ulcerative Colitis Patients. The Open Biomarkers Journal 2021; 11(1) doi: 10.2174/1875318302111010008
74
Marianne Guirgis, Emily Wendt, Lai Mun Wang, Alissa Walsh, Daniel Burger, Robert V. Bryant, Alex Kent, Rebecca Adamson, Oliver Brain, Simon P. L. Travis, Satish Keshav. Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis. Journal of Crohn's and Colitis 2016;  doi: 10.1093/ecco-jcc/jjw174
75
A. C. Ouwehand, S. J. M. ten Bruggencate, A. J. Schonewille, E. Alhoniemi, S. D. Forssten, I. M. J. Bovee-Oudenhoven. Lactobacillus acidophilussupplementation in human subjects and their resistance to enterotoxigenicEscherichia coliinfection. British Journal of Nutrition 2014; 111(3) doi: 10.1017/S0007114513002547
76
Dan Turner, David R. Mack, Jeffrey Hyams, Neal LeLeiko, Anthony Otley, James Markowitz, Yair Kasirer, Aleixo Muise, Cynthia H. Seow, Mark S. Silverberg, Wallace Crandall, Anne M. Griffiths. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. Journal of Crohn's and Colitis 2011; 5(5) doi: 10.1016/j.crohns.2011.05.003
77
Triana Lobatón, Francisco Rodríguez-Moranta, Alicia Lopez, Elena Sánchez, Lorena Rodríguez-Alonso, Jordi Guardiola. A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis. Inflammatory Bowel Diseases 2013; 19(5) doi: 10.1097/MIB.0b013e3182802b6e
78
Trevor Doherty, Edel McDermott, Sarah Jane Delany, Hugh Mulcahy, Therese M. Murphy. Analysis of blood-based DNA methylation signatures of aging and disease progression in inflammatory bowel disease. Human Genetics 2025; 144(11-12) doi: 10.1007/s00439-025-02779-1
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.